Select Language:
Home » About Corealis

About Corealis

At Corealis, our science is solid.

Founded in 2005, Corealis is a premier contract development and manufacturing organization (CDMO). Based in Montreal, Canada, the state-of-the-art facilities, spanning over 45,000 sq ft, boasts modern technological solutions and sophisticated scientific methods, specializing in oral solid dosage (OSD) formulations.

Specifically, Corealis provides:

  • Cutting-edge scientific methods and technology, tailored to the client’s specific requirements
  • Formulation Development and Clinical Supply GMP Manufacturing
  • Specialty HPAPI (as low as 1-10ug/m3 & Potency Category up to 3a-4, able to assess certain highly potent projects)
  • Scientific expert guidance to optimize performance
  • Complete formulation and production data to support regulatory filing

As a top CDMO company, Corealis has established superior quality standards for our services, guiding clients with open communication, achievable goals and respected timelines.

Corealis as your ideal partner

Corealis is recognized as the fastest in the CDMO industry and is trusted for delivering high-quality products, even on the most complex and demanding projects. Using the latest scientific technologies, including managing complex HPAPI, abiding by regulatory guidelines and maintaining a real-time line of communication, our experts enable a smooth process tailored to each client.

Furthermore, our unwavering, hyper client centric commitment, has established us as a consistently and dependable trusted partner.

Corealis executive management

Corealis features a distinguished team of experienced and highly-qualified experts. Guided by the esteemed executive management team including CEO David Leroux-Petersen and founders Patrick Gosselin and Yves Mouget, Corealis is committed to delivering high-quality solutions by offering all clients dedicated support and strategic insight.

Our top-tier certified specialists use the latest, most advanced equipment to ensure the final product delivers seamlessly. Moreover, it remains of outmost importance that our company remains compliant with American, Canadian and European regulatory standards.

Corealis is proud of the expertise and adaptability that sets us apart from other CDMOs and we welcome any questions or comments about potential partnership opportunities.

Contact Corealis

Corealis’ experts are ready to answer any queries about the company’s oral solid dose offering, including its development and manufacturing capabilities.